These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1789275)
1. Synergistic interaction of methotrexate and 6-mercaptopurine in human derived malignant T-ALL and CALLA+ cell lines. De Abreu RA; van Strien F; Lambooy LH; Bökkerink JP Adv Exp Med Biol; 1991; 309A():87-91. PubMed ID: 1789275 [No Abstract] [Full Text] [Related]
2. Biochemical evidence for synergistic combination treatment with methotrexate and 6-mercaptopurine in acute lymphoblastic leukemia. Bökkerink JP; Damen FJ; Hulscher MW; Bakker MA; De Abreu RA Haematol Blood Transfus; 1990; 33():110-7. PubMed ID: 2323622 [No Abstract] [Full Text] [Related]
3. 6-Mercaptopurine metabolism in two leukemic cell lines. Stet EH; De Abreu RA; Janssen YP; Bökkerink JP; Trijbels JM Adv Exp Med Biol; 1991; 309A():83-6. PubMed ID: 1686353 [No Abstract] [Full Text] [Related]
4. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages. Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519 [TBL] [Abstract][Full Text] [Related]
5. Action and sequence dependent interaction of acivicin and 6-thioguanine in human derived malignant T-ALL and CALLA+ cell lines. Trueworthy RC; DeAbreu RA; Lambooy LH; Bökkerink JP; Stet EH Adv Exp Med Biol; 1991; 309A():25-8. PubMed ID: 1789219 [No Abstract] [Full Text] [Related]
6. Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction. Goldman ID Cancer Treat Rep; 1977 Jul; 61(4):549-58. PubMed ID: 884691 [No Abstract] [Full Text] [Related]
7. Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage. Browman GP; Csullog GW Biochem Pharmacol; 1981 Apr; 30(8):869-74. PubMed ID: 7195709 [No Abstract] [Full Text] [Related]
8. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation]. Belousova AK; Gerasimova GK; Vorontsov IN; Greshilov MM Biokhimiia; 1980 Apr; 45(4):609-21. PubMed ID: 6769505 [TBL] [Abstract][Full Text] [Related]
9. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667 [TBL] [Abstract][Full Text] [Related]
10. Intracellular pharmacology and biochemistry of methotrexate and 6-mercaptopurine in childhood acute lymphoblastic leukemia. Keuzenkamp-Jansen CW; Bökkerink JP; Trijbels JM; vd Heijden MA; De Abreu RA Adv Exp Med Biol; 1994; 370():115-8. PubMed ID: 7660872 [No Abstract] [Full Text] [Related]
11. Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts. Bökkerink JP; De Abreu RA; Stet EH; Damen FJ Klin Padiatr; 1992; 204(4):293-8. PubMed ID: 1518268 [TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line. Kano Y; Akutsu M; Kasahara T; Sakamoto S Eur J Cancer; 1991; 27(9):1141-5. PubMed ID: 1835625 [TBL] [Abstract][Full Text] [Related]
13. Collateral sensitivity to methotrexate and dichloromethotrexate of cultured lymphocytic leukemia L1210 cells resistant to 6-mercaptopurine. Wilkoff LJ; Dulmadge EA Proc Soc Exp Biol Med; 1982 May; 170(1):78-81. PubMed ID: 7200608 [No Abstract] [Full Text] [Related]
14. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632 [TBL] [Abstract][Full Text] [Related]
15. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism]. Chen J; Gu LJ; Ying DM; Shen M; Wu HJ Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743 [TBL] [Abstract][Full Text] [Related]
16. Studies relating to the mode of action of methotrexate. II. Studies on sites of action in L-cells in vitro. Borsa J; Whitmore GF Mol Pharmacol; 1969 Jul; 5(4):303-17. PubMed ID: 5306609 [No Abstract] [Full Text] [Related]
17. Comparative effects of DL-glyceraldehyde, 6-mercaptopurine, methotrexate and 5-fluorouracil on the Ehrlich ascites carcinoma in vivo. Bennett LR; Connon FE Int J Cancer; 1966 May; 1(3):291-5. PubMed ID: 5944067 [No Abstract] [Full Text] [Related]
18. Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man. Bertino JR Arthritis Rheum; 1973; 16(1):79-83. PubMed ID: 4540289 [No Abstract] [Full Text] [Related]
19. Determination of the rates of synthesis and degradation of enzymes by complex formation with radioactive ligands. Hanggi UJ FEBS Lett; 1976 Sep; 68(1):35-7. PubMed ID: 964378 [No Abstract] [Full Text] [Related]
20. Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Galpin AJ; Schuetz JD; Masson E; Yanishevski Y; Synold TW; Barredo JC; Pui CH; Relling MV; Evans WE Mol Pharmacol; 1997 Jul; 52(1):155-63. PubMed ID: 9224825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]